Detalhe da pesquisa
1.
SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer.
Mod Pathol
; 32(8): 1217-1231, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30962505
2.
Comparison of PD-L1 immunohistochemistry assays and response to PD-1/L1 inhibitors in advanced non-small-cell lung cancer in clinical practice.
Histopathology
; 74(2): 269-275, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30105871
3.
Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and Adenocarcinoma.
Am J Surg Pathol
; 43(10): 1314-1322, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31318711
4.
Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
Inflamm Bowel Dis
; 24(8): 1780-1790, 2018 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29788391